Related references
Note: Only part of the references are listed.Comparison of day 3 and day 5 thyroglobulin results after thyrogen injection in differentiated thyroid cancer patients
Sait Sager et al.
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2018)
Neck Sonography and Suppressed Thyroglobulin Have High Sensitivity for Identifying Recurrent/Persistent Disease in Patients With Low-risk Thyroid Cancer Treated With Total Thyroidectomy and Radioactive Iodine Ablation, Making Stimulated Thyroglobulin Unnecessary
Jose M. Dominguez et al.
JOURNAL OF ULTRASOUND IN MEDICINE (2017)
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
Bryan R. Haugen et al.
THYROID (2016)
Thyroglobulin in differentiated thyroid cancer
Carol Evans et al.
CLINICA CHIMICA ACTA (2015)
Serial Measurements of Serum Thyroglobulin in Response to Recombinant Human Thyrotropin Stimulation
Richard Weiss et al.
THYROID (2015)
Ability of the rhTSH stimulation test to predict relapse in patients with differentiated thyroid carcinoma, after long-term follow-up
Mafalda Marcelino et al.
ONCOLOGY LETTERS (2015)
Unstimulated Highly Sensitive Thyroglobulin in Follow-up of Differentiated Thyroid Cancer Patients: A Meta-Analysis
Luca Giovanella et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
THE ROLE OF RECOMBINANT HUMAN THYROTROPIN FOR DIAGNOSTIC MONITORING OF PATIENTS WITH DIFFERENTIATED THYROID CANCER
Steven I. Sherman
ENDOCRINE PRACTICE (2013)
Long-Term Clinical Outcome of Differentiated Thyroid Cancer Patients with Undetectable Stimulated Thyroglobulin Level One Year After Initial Treatment
Ji Min Han et al.
THYROID (2012)
Thyroid Cancer Recurrence in Patients Clinically Free of Disease with Undetectable or Very Low Serum Thyroglobulin Values
Richard T. Kloos
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Serum Basal Thyroglobulin Measured by a Second-Generation Assay Correlates with the Recombinant Human Thyrotropin-Stimulated Thyroglobulin Response in Patients Treated for Differentiated Thyroid Cancer
Carole Spencer et al.
THYROID (2010)
Monitoring thyroglobulin in a sensitive immunoassay has comparable sensitivity to recombinant human TSH-stimulated thyroglobulin in follow-up of thyroid cancer patients
Robert C. Smallridge et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later
RT Kloos et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)